Generative AI Market Size, Share & Trends Analysis Report By Component (Software, Service), By Technology (Generative Adversarial Networks, Transformers), By End Use, By Application, By Model, By Customers, By Region, And Segment Forecasts, 2026 - 2033
Description
Generative AI Market Summary
The global generative AI market size was estimated at USD 22.21 billion in 2025 and is projected to reach USD 324.68 billion by 2033, growing at a CAGR of 40.8% from 2026 to 2033. The demand for generative AI applications across industries is being driven by factors such as the expanding use of technologies such as super-resolution, text-to-image conversion, and text-to-video conversion, along with a growing need to modernize workflows.
This trend shows the increasing importance of AI-driven solutions in enhancing operational efficiency and innovation across various sectors. Generative AI uses unverified learning algorithms for tasks such as spam detection, image compression, and data preprocessing, including noise reduction in visual data. Supervised learning algorithms are essential for medical imaging and image classification. These technologies are applied in industries such as BFSI, healthcare, automotive and transportation, IT and telecommunications, and media and entertainment. Generative AI enables organizations to generate new ideas, solve complex problems, and develop innovative products. It also helps save time and costs, increase efficiency, and improve content quality.
The growth of cloud storage solutions has accelerated the generative AI market by providing a strong foundation for technology development and deployment. Cloud storage delivers scalable computing power, allowing businesses to train resource-intensive generative AI model training without substantial capital investment. It enhances data accessibility and collaboration, enabling global teams to efficiently store and share diverse datasets. The pay-as-you-go model reduces financial barriers and supports secure management of sensitive AI projects. Cloud platforms also offer pre-trained models and APIs, streamlining development and optimizing resources.
Global Generative AI Market Report Segmentation
This report offers revenue growth forecasts at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global Generative AI market report based on component, technology, end use, application, model, customers, and region:
The global generative AI market size was estimated at USD 22.21 billion in 2025 and is projected to reach USD 324.68 billion by 2033, growing at a CAGR of 40.8% from 2026 to 2033. The demand for generative AI applications across industries is being driven by factors such as the expanding use of technologies such as super-resolution, text-to-image conversion, and text-to-video conversion, along with a growing need to modernize workflows.
This trend shows the increasing importance of AI-driven solutions in enhancing operational efficiency and innovation across various sectors. Generative AI uses unverified learning algorithms for tasks such as spam detection, image compression, and data preprocessing, including noise reduction in visual data. Supervised learning algorithms are essential for medical imaging and image classification. These technologies are applied in industries such as BFSI, healthcare, automotive and transportation, IT and telecommunications, and media and entertainment. Generative AI enables organizations to generate new ideas, solve complex problems, and develop innovative products. It also helps save time and costs, increase efficiency, and improve content quality.
The growth of cloud storage solutions has accelerated the generative AI market by providing a strong foundation for technology development and deployment. Cloud storage delivers scalable computing power, allowing businesses to train resource-intensive generative AI model training without substantial capital investment. It enhances data accessibility and collaboration, enabling global teams to efficiently store and share diverse datasets. The pay-as-you-go model reduces financial barriers and supports secure management of sensitive AI projects. Cloud platforms also offer pre-trained models and APIs, streamlining development and optimizing resources.
Global Generative AI Market Report Segmentation
This report offers revenue growth forecasts at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global Generative AI market report based on component, technology, end use, application, model, customers, and region:
- Component Outlook (Revenue, USD Million, 2021 - 2033)
- Software
- Service
- Technology Outlook (Revenue, USD Million, 2021 - 2033)
- Generative Adversarial Networks (GANs)
- Transformers
- Variational Auto-encoders
- Diffusion Networks
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Media & Entertainment
- BFSI
- IT & Telecommunication
- Healthcare
- Automotive & Transportation
- Gaming
- Others
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Computer Vision
- NLP
- Robotics & Automation
- Content Generation
- Chatbots & Intelligent Virtual Assistants
- Predictive Analytics
- Others
- Model Outlook (Revenue, USD Million, 2021 - 2033)
- Large Language Models
- Image & Video Generative Models
- Multi-modal Generative Models
- Others
- Customers Outlook (Revenue, USD Million, 2021 - 2033)
- Model Builders
- App Builders
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Latin America
- Brazil
- Middle East & Africa (MEA)
- KSA
- UAE
- South Africa
Table of Contents
100 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. End Use
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR’s Internal Database
- 1.5. Details of primary research
- 1.5.1. Data for primary interviews in North America
- 1.5.2. Data for primary interviews in Europe
- 1.5.3. Data for primary interviews in Asia Pacific
- 1.5.4. Data for primary interviews in Latin America
- 1.5.5. Data for Primary interviews in MEA
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.1.1. Approach 1: Commodity flow approach
- 1.7.2. Volume price analysis (Model 2)
- 1.7.2.1. Approach 2: Volume price analysis
- 1.8. Research Scope and Assumptions
- 1.8.1. List of Secondary Sources
- 1.8.2. List of Primary Sources
- 1.8.3. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
- Chapter 3. Neuromodulation Devices Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Drivers Analysis
- 3.2.1.1. Government funding for research and development
- 3.2.1.2. Technological advancements in neuromodulation devices
- 3.2.1.3. Increasing prevalence of neurological disorders
- 3.2.1.4. Growing reimbursement coverage
- 3.2.1.5. Expanding applications
- 3.2.2. Market Restraints Analysis
- 3.2.2.1. Complex regulatory framework
- 3.2.2.2. Surgery-associated risk
- 3.2.3. Market Opportunity Analysis
- 3.2.3.1. Increasing number of clinical trials and studies
- 3.2.4. Market Challenge Analysis
- 3.2.4.1. Product recalls
- 3.2.4.2. Alternatives to neuromodulation systems
- 3.3. Neuromodulation Devices Market Analysis Tools
- 3.3.1. Porter’s Analysis
- 3.3.1.1. Bargaining power of the suppliers
- 3.3.1.2. Bargaining power of the buyers
- 3.3.1.3. Threats of substitution
- 3.3.1.4. Threats from new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Environmental landscape
- 3.3.2.5. Legal landscape
- Chapter 4. Neuromodulation Devices Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Neuromodulation Devices Market: Product Movement Analysis, 2025 & 2033 (USD Million)
- 4.3. Global Neuromodulation Devices Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
- 4.4. Spinal Cord Stimulators
- 4.4.1. Spinal cord stimulators market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 4.5. Deep Brain Stimulators
- 4.5.1. Deep brain stimulators market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 4.6. Sacral Nerve Stimulators
- 4.6.1. Sacral nerve stimulators market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 4.7. Vagus Nerve Stimulators
- 4.7.1. Vagus nerve stimulators market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 4.8. Gastric Electrical Stimulation
- 4.8.1. Gastric electrical stimulation market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 4.9. Others
- 4.9.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- Chapter 5. Neuromodulation Devices Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Neuromodulation Devices Market: Application Movement Analysis, 2025 & 2033 (USD Million)
- 5.3. Global Neuromodulation Devices Market Size & Trend Analysis, by Application 2021 to 2033 (USD Million)
- 5.4. Parkinson’s Disease
- 5.4.1. Parkinson’s disease market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 5.5. Chronic Pain
- 5.5.1. Chronic pain market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 5.6. Migraine
- 5.6.1. Migraine market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 5.7. Epilepsy
- 5.7.1. Epilepsy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 5.8. Tremor
- 5.8.1. Tremor market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 5.9. Depression
- 5.9.1. Depression market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 5.10. Urinary & Fecal Incontinence
- 5.10.1. Urinary & fecal incontinence market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 5.11. Others
- 5.11.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- Chapter 6. Neuromodulation Devices Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Global Neuromodulation Devices Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
- 6.3. Global Neuromodulation Devices Market Size & Trend Analysis, by End Use 2021 to 2033 (USD Million)
- 6.4. Hospitals & Ambulatory Surgery Centers (ASC)
- 6.4.1. Hospitals & Ambulatory Surgery Centers (ASC) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 6.5. Clinics & Physiotherapy Centers
- 6.5.1. Clinics & physiotherapy centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 6.6. Others
- 6.6.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- Chapter 7. Neuromodulation Devices Market: Regional Estimates & Trend Analysis by Product, Application and End Use
- 7.1. Regional Dashboard
- 7.2. Market Size and Trend Analysis, 2021 to 2033
- 7.3. North America
- 7.3.1. North America neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key country dynamics
- 7.3.2.2. Competitive scenario
- 7.3.2.3. Regulatory framework
- 7.3.2.4. Reimbursement scenario
- 7.3.2.5. U.S. neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.3.3. Canada
- 7.3.3.1. Key country dynamics
- 7.3.3.2. Competitive scenario
- 7.3.3.3. Regulatory framework
- 7.3.3.4. Reimbursement scenario
- 7.3.3.5. Canada neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.3.4. Mexico
- 7.3.4.1. Key country dynamics
- 7.3.4.2. Competitive scenario
- 7.3.4.3. Regulatory framework
- 7.3.4.4. Reimbursement scenario
- 7.3.4.5. Mexico neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4. Europe
- 7.4.1. Europe neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.2. UK
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Competitive scenario
- 7.4.2.3. Regulatory framework
- 7.4.2.4. Reimbursement scenario
- 7.4.2.5. UK neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.3. Germany
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Competitive scenario
- 7.4.3.3. Regulatory framework
- 7.4.3.4. Reimbursement scenario
- 7.4.3.5. Germany neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.4. France
- 7.4.4.1. Key country dynamics
- 7.4.4.2. Competitive scenario
- 7.4.4.3. Regulatory framework
- 7.4.4.4. Reimbursement scenario
- 7.4.4.5. France neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Key country dynamics
- 7.4.5.2. Competitive scenario
- 7.4.5.3. Regulatory framework
- 7.4.5.4. Reimbursement scenario
- 7.4.5.5. Italy neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Key country dynamics
- 7.4.6.2. Competitive scenario
- 7.4.6.3. Regulatory framework
- 7.4.6.4. Reimbursement scenario
- 7.4.6.5. Spain neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.7. Sweden
- 7.4.7.1. Key country dynamics
- 7.4.7.2. Competitive scenario
- 7.4.7.3. Regulatory framework
- 7.4.7.4. Reimbursement scenario
- 7.4.7.5. Sweden neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.8. Denmark
- 7.4.8.1. Key country dynamics
- 7.4.8.2. Competitive scenario
- 7.4.8.3. Regulatory framework
- 7.4.8.4. Reimbursement scenario
- 7.4.8.5. Denmark neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.9. Norway
- 7.4.9.1. Key country dynamics
- 7.4.9.2. Competitive scenario
- 7.4.9.3. Regulatory framework
- 7.4.9.4. Reimbursement scenario
- 7.4.9.5. Norway neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Asia Pacific neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.2. China
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Competitive scenario
- 7.5.2.3. Regulatory framework
- 7.5.2.4. Reimbursement scenario
- 7.5.2.5. China neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.3. Japan
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Competitive scenario
- 7.5.3.3. Regulatory framework
- 7.5.3.4. Reimbursement scenario
- 7.5.3.5. Japan neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.4. India
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Competitive scenario
- 7.5.4.3. Regulatory framework
- 7.5.4.4. Reimbursement scenario
- 7.5.4.5. India neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.5. South Korea
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Competitive scenario
- 7.5.5.3. Regulatory framework
- 7.5.5.4. Reimbursement scenario
- 7.5.5.5. South Korea neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.6. Australia
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Competitive scenario
- 7.5.6.3. Regulatory framework
- 7.5.6.4. Reimbursement scenario
- 7.5.6.5. Australia neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.7. Thailand
- 7.5.7.1. Key country dynamics
- 7.5.7.2. Competitive scenario
- 7.5.7.3. Regulatory framework
- 7.5.7.4. Reimbursement scenario
- 7.5.7.5. Thailand neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6. Latin America
- 7.6.1. Latin America neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Competitive scenario
- 7.6.2.3. Regulatory framework
- 7.6.2.4. Reimbursement scenario
- 7.6.2.5. Brazil neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Competitive scenario
- 7.6.3.3. Regulatory framework
- 7.6.3.4. Reimbursement scenario
- 7.6.3.5. Argentina neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7. Middle East and Africa
- 7.7.1. Middle East and Africa neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.2. South Africa
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Competitive scenario
- 7.7.2.3. Regulatory framework
- 7.7.2.4. Reimbursement scenario
- 7.7.2.5. South Africa neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.3. Saudi Arabia
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Competitive scenario
- 7.7.3.3. Regulatory framework
- 7.7.3.4. Reimbursement scenario
- 7.7.3.5. Saudi Arabia neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.4. UAE
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Competitive scenario
- 7.7.4.3. Regulatory framework
- 7.7.4.4. Reimbursement scenario
- 7.7.4.5. UAE neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.5. Kuwait
- 7.7.5.1. Key country dynamics
- 7.7.5.2. Competitive scenario
- 7.7.5.3. Regulatory framework
- 7.7.5.4. Reimbursement scenario
- 7.7.5.5. Kuwait neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis by Key Market Participants
- 8.2. Company Categorization
- 8.3. Company Market Share Analysis, 2025
- 8.4. Company Heat Map Analysis
- 8.5. Strategy Mapping
- 8.5.1. Expansion
- 8.5.2. Mergers & Acquisition
- 8.5.3. Partnerships & Collaborations
- 8.5.4. New Product Launches
- 8.5.5. Research And Development
- 8.5.6. Company Profiles
- 8.5.7. Abbott (St. Jude Medical)
- 8.5.7.1. Company overview
- 8.5.7.2. Financial performance
- 8.5.7.3. Product Benchmarking
- 8.5.7.4. Strategic initiatives
- 8.5.8. Medtronic
- 8.5.8.1. Company overview
- 8.5.8.2. Financial performance
- 8.5.8.3. Product Benchmarking
- 8.5.8.4. Strategic initiatives
- 8.5.9. Boston Scientific Corporation
- 8.5.9.1. Company overview
- 8.5.9.2. Financial performance
- 8.5.9.3. Product Benchmarking
- 8.5.9.4. Strategic initiatives
- 8.5.10. Aleva Neurotherapeutics
- 8.5.10.1. Company overview
- 8.5.10.2. Financial performance
- 8.5.10.3. Product Benchmarking
- 8.5.10.4. Strategic initiatives
- 8.5.11. Nexstim
- 8.5.11.1. Company overview
- 8.5.11.2. Financial performance
- 8.5.11.3. Product Benchmarking
- 8.5.11.4. Strategic initiatives
- 8.5.12. LivaNova PLC
- 8.5.12.1. Company overview
- 8.5.12.2. Financial performance
- 8.5.12.3. Product Benchmarking
- 8.5.12.4. Strategic initiatives
- 8.5.13. Neuropace Inc.
- 8.5.13.1. Company overview
- 8.5.13.2. Financial performance
- 8.5.13.3. Product Benchmarking
- 8.5.13.4. Strategic initiatives
- 8.5.14. Mainstay Medical
- 8.5.14.1. Company overview
- 8.5.14.2. Financial performance
- 8.5.14.3. Product Benchmarking
- 8.5.14.4. Strategic initiatives
- 8.5.15. Saluda Medical Pty Ltd
- 8.5.15.1. Company overview
- 8.5.15.2. Financial performance
- 8.5.15.3. Product Benchmarking
- 8.5.15.4. Strategic initiatives
- 8.5.16. Biotronik
- 8.5.16.1. Company overview
- 8.5.16.2. Financial performance
- 8.5.16.3. Product Benchmarking
- 8.5.16.4. Strategic initiatives
- 8.5.17. electroCore, Inc.
- 8.5.17.1. Company overview
- 8.5.17.2. Financial performance
- 8.5.17.3. Product Benchmarking
- 8.5.17.4. Strategic initiatives
- 8.5.18. MicroTransponder Inc.
- 8.5.18.1. Company overview
- 8.5.18.2. Financial performance
- 8.5.18.3. Product Benchmarking
- 8.5.18.4. Strategic initiatives
- 8.5.19. tVNS Technologies GmbH
- 8.5.19.1. Company overview
- 8.5.19.2. Financial performance
- 8.5.19.3. Product Benchmarking
- 8.5.19.4. Strategic initiatives
- 8.5.20. Laborie
- 8.5.20.1. Company overview
- 8.5.20.2. Financial performance
- 8.5.20.3. Product Benchmarking
- 8.5.20.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
